Enjoy complimentary customisation on priority with our Enterprise License!
The Intravenous (IV) Fluid Bags Market size is estimated to grow by USD 846.08 million, at a CAGR of 6.01% between 2023 and 2028.
As governments around the world focus on improving healthcare systems and services, there has been a significant increase in the demand for critical medical supplies such as intravenous fluid bags. In developing countries like India, the level of healthcare expenditure has increased over the years. In addition, the increasing focus on improving healthcare facilities, particularly in developing countries, is driving the growth of the intravenous fluid bags market. The global market is seeing significant growth in Asia-Pacific as well as Latin America, where countries are investing heavily in modernizing healthcare facilities to meet the medical requirements of their growing populations. Thus, an increase in healthcare expenditure by government and constitutional bodies globally will drive the market growth during the forecast period.
Technavio has segmented the market into Type, End-user, and Geography
It also includes an in-depth analysis of drivers, market trends and analysis, and challenges. Our report examines historic data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the PVC material segment will be significant during the forecast period. Polyvinyl chloride (PVC) fluid bags are one of the most significant market segments by type in the market due to their widespread usage and unique features. The popularity of PVC intravenous fluid bags is due to their affordability, versatility, and ease of production. PVCs' inherent characteristics make it a preferred material for medical applications.
Get a glance at the market contribution of various segments Download PDF Sample
The PVC material segment was the largest and was valued at USD 1,050.48 million in 2018. However, the PVC material segment is facing environmental challenges. PVC is linked to environmental issues during the production and disposal stages. There is a growing trend towards eco-friendly alternatives. For example, polyolefin-based intravenous fluid bags are becoming increasingly popular in the healthcare industry. Despite these challenges, PVC remains the market leader due to its demonstrated performance, low cost, and widespread acceptance. Therefore, these factors under the PVC segment are expected to increase the growth of the market during the forecast period.
Hospitals account for a significant share of the market due to the wide variety of medical conditions and therapies that require intravenous therapy. The increasing number of chronic conditions, surgical procedures, and emergency medical interventions in hospitals are driving the growth of intravenous fluid bags in hospitals. Furthermore, growing demand for intravenous therapy in various medical settings, patient safety, and technological innovation are driving the growth of this intravenous fluid bags market segment. As hospitals continue to focus on efficient and safe patient treatment, the market is on a trajectory of continuous growth driven by innovation. These factors under the hospital segment will boost the growth of the market during the forecast period.
Home healthcare is one of the most important end-user segments that includes a large number of patients receiving medical treatment in the convenience of their own homes. The role of intravenous fluid bags in this setting is critical as they allow fluids, medications, and nutrients to be directly injected into the patient's bloodstream. Several key vendors are increasing the importance of home healthcare in the IV fluid bags market. They include Baxter International Inc., B. Braun SE, Fresenius SE, and Co. KGaA. These companies are investing in research and development (R&D) to develop and supply intravenous fluid bags that are easy to use, portable, and safe for home healthcare patients. These factors will, therefore, increase the demand for the home healthcare segment and will propel the growth of the market during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the intravenous (IV) fluid bags market during the forecast period. North America is one of the most important regions in the IV fluid bags market and plays a key role in driving the industry growth. The region's importance is due to several factors, including a well-developed healthcare system, a strong regulatory environment, and an abundance of chronic diseases. In addition, North America's established healthcare system, with its advanced medical facilities and patient-centric approach to care, is a key factor in the growing adoption of intravenous therapies.
Further, across the region, in the US, Canada, and Mexico, hospitals, clinics, and outpatient surgery centers use intravenous fluid bags extensively for a wide range of medical purposes, from basic hydration to more critical care situations. Regional governments in Canada are responsible for funding, managing, and providing health services, as well as overseeing providers of intravenous fluid bags. These factors will, therefore, drive the growth of the regional market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Alfa Laboratories SAL - The company offers intravenous fluid bags such as Sodium Chloride Injection USP IV injection. The IV bag comes with antimicrobial agents and is intended only for use as a single-dose injection.
Qualitative and quantitative market growth analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
The aging population worldwide is notably driving market growth. As the world's population ages, there is an increasing need for healthcare services. One of these services is intravenous therapy. As the number of elderly people increases, so does the demand for intravenous fluid bags. According to the World Bank data, the global geriatric population, i.e., people 65 years of age and above, constitute about 10 % of the total population. As the population ages, they are affected by a variety of health issues that require medical interventions. Older adults often struggle with dehydration, malnourishment, and chronic conditions that require intravenous therapies.
Moreover, the number of people aged 65 and over now surpasses the number of children under the age of 5 in the world. Worldwide, the number of people 65 and over is projected to reach 1,5 billion by 2050. As the world's population ages, chronic diseases are projected to increase exponentially, which will thereby drive the market during the forecast period.
Rising focus on single-use and sterility is an emerging trend shaping market growth. The rising demand for single-use intravenous fluid bags is mainly driven by cross-contamination concerns and the need to reduce the risk of infection. The use of single-use intravenous fluid bags eliminates the cleaning and sterilization process, increasing the level of sterility while reducing the risk of transmission of infections in healthcare settings. This is especially important in the prevention of hospital-acquired infections, which is a major concern for healthcare facilities around the world.
In addition, aseptic filling methods and barrier systems have enabled manufacturers to produce sterile IV bags in sterile, controlled environments, ensuring sterility throughout the entire production process. Not only does this meet regulatory standards, but it also addresses concerns about bacterial contamination, making disposable intravenous fluid bags a preferred option among healthcare professionals. Such factors are expected to increase the growth of the market during the forecast period.
Issues related to the availability of raw materials and high pricing a significant challenges hindering market growth. Varying raw material availability is one of the major challenges manufacturers face around the globe. Supply chain disruptions, such as geopolitical tensions or natural disasters, can have a significant impact on intravenous fluid bag production. For example, when polyvinylchloride, a material that is widely used in intravenous fluid bag manufacturing, goes out of stock, intravenous fluid bags become unavailable on the global market. Due to the shortage of polyvinylchloride, production times increase, production delays occur, and overall production costs increase.
In addition, the cost of raw materials plays an important role in the market. Oil prices fluctuate, as many plastics are made from petroleum. The cost of manufacturing intravenous fluid bags is directly related to the price of oil. Regulatory changes and environmental pressures may also lead to a transition to more sustainable and biodegradable materials, potentially changing the cost structure in the industry. These factors will thereby restrict the market growth and trends during the forecast market.
The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
Intravenous Fluid Bags Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.01% |
Market Growth 2024-2028 |
USD 846.08 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.37 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 32% |
Key countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Alfa Laboratories SAL, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., DL Chemical, Fosmo Med, Fresenius SE and Co. KGaA, ICU Medical Inc., Macopharma, Medicopack, Otsuka Holdings Co. Ltd., Pharmaceutical Solutions Industry, Polifarma Ilac San ve Tic AS, PolyCine GmbH, RENOLIT SE, Sartorius AG, SIPPEX, Technoflex, The Metrix Co., Vioser SA, Wellpharma, and West Pharmaceutical Services Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.